Sherbrooke Park Advisers’s GeneDx Holdings WGS Stock Holding History

Sherbrooke Park Advisers’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-11,822	Closed	-$108K	–	1231
2024 Q1	$108K	Buy	+11,822	New	+$71K	0.02%	790

Other funds holding WGS

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Blackstone Inc New York $39B AUM 18.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Sherbrooke Park Advisers's WGS Position: Q2 2024 in Review

Sherbrooke Park Advisers sold out of GeneDx Holdings (WGS) in Q2 2024, closing a stake of 11,822 shares — an estimated $108K sold.

Sherbrooke Park Advisers first reported a position in WGS in Q1 2024 and held it in 1 quarter. The position peaked at $108K in Q1 2024. 86 funds tracked by Wall St. Rank hold WGS as of Q2 2024.

Sherbrooke Park Advisers reported no remaining GeneDx Holdings position as of Q2 2024 after selling out during the quarter.
Sherbrooke Park Advisers sold 11,822 GeneDx Holdings shares in Q2 2024, an estimated $108K.
Sherbrooke Park Advisers first reported a position in GeneDx Holdings in Q1 2024 and held it in 1 quarter.
Sherbrooke Park Advisers's GeneDx Holdings position peaked at $108K in Q1 2024.
86 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2024.

Based on Sherbrooke Park Advisers's 13F filing for Q2 2024, filed 14 Aug 2024.